Physician profile
Karole Davis
NPI 1477720829
$8,215.49
in general payments reported to CMS, 2019-2025
9 companies · $873 in 2025
The $873 reported for 2025 was more than what a typical Surgical Critical Care provider received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,671 · 2021: $87.27 · 2024: $1,584 · 2025: $873.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,643 · Food and Beverage: $815.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,643.16 |
| Food and Beverage | $814.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,609.01 | 2019 | |
| Atricure, INC. | $1,481.09 | 2024 | |
| Zimmer Biomet Holdings, INC. | $814.13 | 2025 | Advantagerib, Ribfix Titan |
| Stryker Corporation | $121.50 | 2021-2024 | 1788 |
| Integra Lifesciences Corporation | $69.06 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Polynovo North America LLC | $59.21 | 2025 | Novosorb Btm |
| Avanos Medical | $31.50 | 2019 | |
| Baxter Healthcare | $18.95 | 2019 | |
| Smith+Nephew, INC. | $11.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karole Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.